Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05120635

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

Conditions

Interventions

TypeNameDescription
DEVICEDeep Brain StimulationDeep brain stimulation will be used
BEHAVIORALVirtual and augmented reality tasksVirtual and augmented reality tasks will be used.

Timeline

Start date
2021-10-01
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2021-11-15
Last updated
2025-12-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05120635. Inclusion in this directory is not an endorsement.